{"id":44987,"date":"2022-06-13T11:01:25","date_gmt":"2022-06-13T09:01:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/"},"modified":"2022-06-13T11:01:25","modified_gmt":"2022-06-13T09:01:25","slug":"biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/","title":{"rendered":"Biotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne\u2019s Disease Assay"},"content":{"rendered":"
\n

LOS ANGELES–(BUSINESS WIRE)–Auckland-based biotechnology company Pictor Limited has been developing an accurate, affordable multiplexed diagnostic test for Mycobacterium avium paratuberculosis<\/i> (MAP) \u2013 also known as Johne\u2019s disease, that could save the New Zealand dairy industry upwards of $80 million a year in lost production.\n<\/p>\n

<\/a><\/p>\n

\n\u201cThe PictArray\u2122 MAP assay would be a positive addition to national control programs to help in the eradication of Johne\u2019s disease from the dairy industry,\u201d says Pictor\u2019s Director of Research and Development, Dr. Natasha Gordon, who will be presenting at a Johne\u2019s disease conference this week in Dublin, Ireland.\n<\/p>\n

\nThe PictArray multiplex enzyme-linked immunosorbent assay (ELISA) technology allows multiple biomarkers to be tested in a single well. This feature increases the information gained by the clinical testing laboratory, enabling improved disease management on the farm. Conventional ELISA takes a snapshot of a disease at one moment in time, while the PictArray multiplex allows complex diseases to be monitored through different stages of infection using biomarkers that present at different time points during the infection cycle, including asymptomatic stages. Earlier detection of Johne\u2019s disease would allow infected animals to be removed from herds sooner, minimizing transmission.\n<\/p>\n

\n\u201cOur PictArray MAP assay could facilitate improved biosecurity, and support trade, because tests can be performed quickly and accurately when importing, exporting or moving livestock and associated products between local locations, resulting in safe transportation without the risk of spreading infection,\u201d says Gordon.\n<\/p>\n

\nThe research project is led by Pictor in a collaboration with Dr Rao Dukkipati, senior lecturer at Massey University, and builds on long-term research at Massey University by Associate Professor Alan Murray. Pictor received a $404,040 grant from the New Zealand Government\u2019s Ministry for Primary Industries\u2019 Sustainable Food and Fibre Futures fund to develop the test and Pictor has filed a PCT application for this multiplexed assay.\n<\/p>\n

\nAbout Pictor<\/b>\n<\/p>\n

\nPictor is an in vitro diagnostics company that offers a patented multiplexed platform for highly accurate and efficient testing of complex and infectious diseases for human and animal health. PictArray\u2122 multiplexed technology makes it possible to test multiple disease markers in a single test simultaneously \u2014 with higher sensitivity, faster throughput, and reduced turn-around time. The company\u2019s lead product, PictArray\u2122 SARS-CoV-2 IgG ELISA Kit, enables more informed clinical intervention to manage the threat of COVID-19. For more information, please visit http:\/\/pictordx.com<\/a>, https:\/\/www.linkedin.com\/company\/pictorltd<\/a>, and @PictorLtd on Twitter.\n<\/p>\n

\nAbout Massey University<\/b>\n<\/p>\n

\nEstablished in 1927 and located in Palmerston North, New Zealand, Massey University offers internationally recognised teaching and research. The School of Agriculture and Environment \u2013 Te Kura M\u0101tauranga m\u014d Ahuwhenua me Te Taiao aims to develop a balance between social, environmental, and economic outcomes for production and sustainability. www.massey.ac.nz<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact<\/b>
Grant Zehnder
\n
grant@bospar.com<\/a>
440.714.7958\n<\/p>\n

\nBusiness\/Sales Contact<\/b>
Howard Moore
\n
h.moore@pictordx.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–Auckland-based biotechnology company Pictor Limited has been developing an accurate, affordable multiplexed diagnostic test for Mycobacterium avium paratuberculosis (MAP) \u2013 also known as Johne\u2019s disease, that could save the New Zealand dairy industry upwards of $80 million a year in lost production. \u201cThe PictArray\u2122 MAP assay would be a positive addition to national … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-44987","format-standard","category-industry"],"yoast_head":"\nBiotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne\u2019s Disease Assay - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne\u2019s Disease Assay - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES–(BUSINESS WIRE)–Auckland-based biotechnology company Pictor Limited has been developing an accurate, affordable multiplexed diagnostic test for Mycobacterium avium paratuberculosis (MAP) \u2013 also known as Johne\u2019s disease, that could save the New Zealand dairy industry upwards of $80 million a year in lost production. \u201cThe PictArray\u2122 MAP assay would be a positive addition to national ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-13T09:01:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220613005126\/en\/1483489\/21\/Pictor.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Biotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne\u2019s Disease Assay\",\"datePublished\":\"2022-06-13T09:01:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\\\/\"},\"wordCount\":487,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220613005126\\\/en\\\/1483489\\\/21\\\/Pictor.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\\\/\",\"name\":\"Biotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne\u2019s Disease Assay - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220613005126\\\/en\\\/1483489\\\/21\\\/Pictor.jpg\",\"datePublished\":\"2022-06-13T09:01:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220613005126\\\/en\\\/1483489\\\/21\\\/Pictor.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220613005126\\\/en\\\/1483489\\\/21\\\/Pictor.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne\u2019s Disease Assay\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne\u2019s Disease Assay - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/","og_locale":"en_US","og_type":"article","og_title":"Biotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne\u2019s Disease Assay - Pharma Trend","og_description":"LOS ANGELES–(BUSINESS WIRE)–Auckland-based biotechnology company Pictor Limited has been developing an accurate, affordable multiplexed diagnostic test for Mycobacterium avium paratuberculosis (MAP) \u2013 also known as Johne\u2019s disease, that could save the New Zealand dairy industry upwards of $80 million a year in lost production. \u201cThe PictArray\u2122 MAP assay would be a positive addition to national ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-13T09:01:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220613005126\/en\/1483489\/21\/Pictor.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Biotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne\u2019s Disease Assay","datePublished":"2022-06-13T09:01:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/"},"wordCount":487,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220613005126\/en\/1483489\/21\/Pictor.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/","url":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/","name":"Biotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne\u2019s Disease Assay - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220613005126\/en\/1483489\/21\/Pictor.jpg","datePublished":"2022-06-13T09:01:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220613005126\/en\/1483489\/21\/Pictor.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220613005126\/en\/1483489\/21\/Pictor.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Biotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne\u2019s Disease Assay"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44987"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44987\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}